TNF and cystic fibrosis: The reported “ET-signature” (IL10high/IL12low/IL23low) was corroborated in this new cohort of CF patients (n = 14) (Fig. 1A–1C) as well as a low TNFα production after ex vivo LPS challenge (Fig. 1D).